Indonesia-China vaccine trials run smoothly  New Straits TimesView Full coverage on Google News
NO side effects have been recorded thus far, as the development of the Covid-19 vaccine between Indonesia and China progresses.

Indonesia-China vaccine trials run smoothly | New Straits Times

BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60 | The Star

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

Covid-19 vaccine trials are advancing fast – but anti-vaccine sentiment is growing tooCovid-19 vaccine trials are advancing fast – but anti-vaccine sentiment is growing too

‘Stick your vaccine up your arse’ – the Covid-19 vaccine, the science and the sceptics

The CDC put out a central playbook for how to distribute the shots. But how states will address these guidelines is anything but uniform.The CDC put out a central playbook for how to distribute the shots. But how states will address these guidelines is anything but uniform.

In the US, 50 States Could Mean 50 Vaccine Rollout Strategies | WIRED

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.

China's Covid-19 vax is safe, prompts antibody response: Lancet | greatandhra.com

The head of the UK Vaccine Taskforce says it would not mean that life would get back to normal straight away.The head of the UK Vaccine Taskforce says it would not mean that life would get back to normal straight away.

sign-in

A $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine thatA $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet

$60 experimental coronavirus vaccine rolled out in eastern Chinese city | Deccan Herald

India News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk populIndia News: As the world prepares for a vaccine against Covid-19, India has started identifying around 30 crore priority beneficiaries, including high-risk popul

Covid-19: Govt identifying 30 crore who will get vaccine on priority | India News - Times of India

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial ...

Preliminary results find COVID-19 vaccine candidate based on inactivated SARS-CoV-2 virus is safe

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study | Health

Having struggled to contain the spread of the coronavirus, the country has put all its chips on securing access to an effective vaccine.Having struggled to contain the spread of the coronavirus, the country has put all its chips on securing access to an effective vaccine.

Indonesia Secures Access to Promising British COVID-19 Vaccine – The Diplomat

A Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinicalA Chinese drug developer is offering an experimental coronavirus vaccine to students going abroad in a strategy health experts say raises safety and ethical concerns. China National Biotech Group has two vaccine candidates out of five from Chinese developers that are in the final stages of clinical

Chinese company offers coronavirus vaccine to students

The state anticipates the first shipment of a COVID-19 vaccine to arrive in Kentucky "in late 2020 or early 2021," Public Health Commissioner Dr. Steven Stack said in a newsThe state anticipates the first shipment of a COVID-19 vaccine to arrive in Kentucky "in late 2020 or early 2021," Public Health Commissioner Dr. Steven Stack said in a news

Kentucky health officials say statewide distribution of COVID-19 vaccines could take 'a year or more' | Coronavirus | wdrb.com

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

People working or living in nursing homes, hospital staff and first responders likely will be the first to get a COVID-19 vaccine in Colorado, but even they may have to wait if supplies are short.People working or living in nursing homes, hospital staff and first responders likely will be the first to get a COVID-19 vaccine in Colorado, but even they may have to wait if supplies are short.

Colorado COVID-19 vaccine plan will prioritize health care workers, nursing home residents

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...

US$60 experimental COVID-19 vaccine rolled out in east Chinese city - CNA

North Dakota has submitted its COVID-19 vaccination plan to the Centers for Disease Control and Prevention on Friday, Gov. Doug Burgum and the North Dakota Department of Health announced. A press release from the Joint Information Center says North Dakota’s planning efforts are based on CDC guidance to anticipate a phased availability of vaccines within […]North Dakota has submitted its COVID-19 vaccination plan to the Centers for Disease Control and Prevention on Friday, Gov. Doug Burgum and the North Dakota Department of Health announced. A press r…

Burgum, Department of Health announce completion of COVID-19 vaccination plan | KX NEWS

The results came from a combined Phase I and Phase II trial involving more than 600 healthy adults conducted between April 29 and July 30.The results came from a combined Phase I and Phase II trial involving more than 600 healthy adults conducted between April 29 and July 30.

Coronavirus vaccine candidate from China's CNBG shows promise in human test, study shows - News | Khaleej Times

The race for a COVID-19 vaccine is heating up as cases rise worldwide. The chair of the U.K. Vaccine Taskforce says there&#039;s a slim chance a vaccine may be ready by Christmas. CBS News foreign correspondent Charlie D&#039;Agata reports.The race for a COVID-19 vaccine is heating up as cases rise worldwide. The chair of the U.K. Vaccine Taskforce says there's a slim chance a vaccine may be ready by Christmas. CBS News foreign correspondent Charlie D'Agata reports.

Race to find a COVID-19 vaccine as cases rise worldwide - CBS News

Dr Suresh Jadhav, executive director of the Serum Institute of India, told The Indian Express that India is heading fast towards vaccine development, as two manufacturers are already in phase-3 trial and one in the phase-2 trial, and more players are joining the race.Dr Suresh Jadhav, executive director of the Serum Institute of India, told The Indian Express that India is heading fast towards vaccine development, as two manufacturers are already in phase-3 trial and one in the phase-2 trial, and more players are joining the race.

India may get Covid vaccine by March, says Serum official | India News,The Indian Express

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.

North Carolina unveils plan to deploy coronavirus vaccine

China has already given essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine.. Read more at straitstimes.com.East Asia News -China has already given essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine.. Read more at straitstimes.com.

$80 unproven coronavirus vaccine rolled out in eastern Chinese city of Jiaxing, East Asia News & Top Stories - The Straits Times

The goal is to immunize everyone who is eligible for and wants a COVID-19 vaccineThe goal is to immunize everyone who is eligible for and wants a COVID-19 vaccine

NCDHHS submits plan to CDC prioritizing COVID-19 vaccine

The plan lays out an initial framework for who will receive the first doses of the vaccine, who will administer those doses and how the state will manage the process.The plan lays out an initial framework for who will receive the first doses of the vaccine, who will administer those doses and how the state will manage the process.

Connecticut just submitted its draft plan for COVID-19 vaccine distribution. Here’s what you need to know - Hartford Courant

North Carolina health officials submitted a COVID-19 vaccination plan to the Centers for Disease Control and Prevention (CDC) on Friday, according to a statement from the North Carolina Department of Health and Human Services. The full statement is provided below: “North Carolina today submitted to the Centers for Disease Control and Prevention its COVID-19 Vaccination Plan. […]North Carolina health officials submitted a COVID-19 vaccination plan to the Centers for Disease Control and Prevention (CDC) on Friday, according to a statement from the North Carolina Department …

NC health officials submit COVID-19 vaccination plan to CDC | myfox8.com

This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.

China's Covid-19 vaccine candidate is safe and prompts antibody response - early results from study

LAS VEGAS (FOX5) -- Nevada's Department of Health and Human Services, Division of Public and Behavioral Health submitted a vaccine program to the Centers for Disease Control and Prevention.LAS VEGAS (FOX5) -- Nevada's Department of Health and Human Services, Division of Public and Behavioral Health submitted a vaccine program to the Centers for Disease Control and Prevention.

Nevada submits COVID-19 vaccine program to CDC | Coronavirus | fox5vegas.com

A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...

€50 experimental COVID-19 vaccine rolled out in east Chinese city

The plan submitted to the federal government Friday calls for vaccinating 80% of Maine's 1.3 million people within 12 weeks, in a massive statewide effort.

Maine’s plan to distribute vaccine stresses racial equity, health care workers and the elderly - Portland Press Herald

Serum Institute of India (SII) can manufacture 700-800 million vaccine doses every year. said executive director Dr Suresh Jadhav.Serum Institute of India (SII) can manufacture 700-800 million vaccine doses every year. said executive director Dr Suresh Jadhav.

Oxford COVID-19 vaccine likely to be ready by March 2021: Serum Institute of India

Treatment is safe and elicits an antibody response, preliminary results have shownTreatment is safe and elicits an antibody response, preliminary results have shown

'Enouraging' Chinese Covid vaccine shows early promise - Wales Online

403 Missing Auth Token

Fresh hope of a Covid-19 vaccine has emerged from a new trial showing an experimental Chinese jab is "safe and elicits an antibody response" to fight the virus.Fresh hope of a Covid-19 vaccine has emerged from a new trial showing an experimental Chinese jab is "safe and elicits an antibody response" to fight the virus.

Chinese vaccine trial offers fresh hope in war against pandemic - Independent.ie

A COVID-19 vaccine has yet to be federally approved, but the Rhode Island Department of Health is already making preparations for how it will be distributed once it's made available.A COVID-19 vaccine has yet to be federally approved, but the Rhode Island Department of Health is already making preparations for how it will be distributed once it’s made available.

RI plan would prioritize certain groups for COVID-19 vaccine | WPRI.com

Russia registered its second coronavirus vaccine on 14 October.Developed by Vector State Research Center of Virology and Biotechnology, the EpiVacCorona vaccine completed its early stage human trials last monthRussia registered its second coronavirus vaccine on 14 October.Developed by Vector State Research Center of Virology and Biotechnology, the EpiVacCorona vaccine completed its early stage human trials last month

COVID-19 vaccine: WHO in talks with Russia on its second vaccine EpiVacCorona

It's important to remember that it isn't all doom and gloom - and there are reasons to be optimisticIt's important to remember that it isn't all doom and gloom - and there are reasons to be optimistic

Covid-19 Ireland good news: Christmas hope and vaccine timeline emerges - Irish Mirror Online

The documents were submitted to the Center of Disease Control and Prevention for review and approval.The documents were submitted to the Center of Disease Control and Prevention for review and approval.

Iowa health officials submit plan to CDC on distributing vaccine when available

China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.

Chinese firm giving unproven COVID-19 vaccine to students going abroad - Business Insider